期刊文献+

他汀类药物与新发糖尿病关系的研究进展 被引量:10

Research Development of Relation Between Statins and New Onset Diabetes Mellitus
下载PDF
导出
摘要 他汀类药物是心血管疾病治疗的常用药物,但是他汀类药物的不良反应需要心血管医师的关注,本文就他汀类药物与新发糖尿病之间关系的研究做了综述,通过对国内外研究进行分析,认为他汀类药物与新发糖尿病有关,但是新发糖尿病的发生率低,不同种类、不同剂量的他汀类药物新发糖尿病发生率不一。对于存在肥胖、代谢综合征等危险因素的患者来说,应用他汀类药物发生新发糖尿病的风险更大,但是其心血管事件上的获益大于其对新发糖尿病的影响。 Statins are commonly used drugs to cardiovascular disease treatment,but the adverse drug reactions of statins need cardiologists' attention. A review was made on the research of relation between statins and new onset diabetes mellitus. By comparative study between domestic and foreign researches,it was shown that statins is indeed related with new onset diabetes mellitus,while the incidence is low and the incidence varies with different categories and different dosages of statins. For patients with obesity and metabolic syndrome,the application of statins brings higher risk for new onset diabetes,but the benefit it brings to cardiovascular events outweigh its influence on new onset diabetes.
作者 南京 杨水祥
出处 《中国全科医学》 CAS CSCD 北大核心 2016年第6期622-627,共6页 Chinese General Practice
关键词 糖尿病 他汀类药物 综述 Diabetes mellitus Statins Review
  • 相关文献

参考文献38

  • 1Expert Dyslipidemia Panel, Grundy SM. An international atherosclerosis society position paper: global recommendations for the management of dyslipidemia [J]. J Clin Lipidol, 2013, 7 (6): 561-565.
  • 2Katz DH, Intwala SS, Stone NJ. Addressing statin adverse effects in the clinic: the 5 Ms [J]. J Cardiovasc Pharmacol Ther, 2014, 19 (6) : 533 -542.
  • 3Sattar N, Preiss D, Murray HM, et al. Statins and risk of incident diabetes: a collaborative meta- analysis of randomised statin trials [J]. Lancet, 2010, 375 (9716): 735-742.
  • 4Ridker PM, Pradhan A, MacFadyen JG, et al. Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial. [J]. Lancet, 2012, 380 (9841) : 565 -571.
  • 5Waters DD, Ho JE, Boekholdt SM, et al. Cardiovascular event reduction versus new- onset diabetes during atorvastatin therapy: effect of baseline risk factors for diabetes [ J ]. J Am Coll Cardiol, 2013, 61 (2): 148-152.
  • 6Shen L, Shah BR, Reyes EM, et al. Role of diuretics, 13 blockers, and statins in increasing the risk of diabetes in patients with impaired glucose tolerance: reanalysis of data from the NAVIGATOR study [J]. BMJ, 2013, 347: f6745.
  • 7Preiss D, Welsh P, Murray HM, et al. Fasting plasma glucose in non - diabetic participants and the risk for incident cardiovascular events, diabetes, and mortality: results from WOSCOPS 15 -year follow -up [J]. Eur Heart J, 2010, 31 (10): 1230-1236.
  • 8Colbert JD, Stone JA. Statin use and the risk of incident diabetes mellitus: a review of the literature [J]. Can J Cardiol, 2012, 28 (5) : 581 -589.
  • 9Kim W, Hong MJ, Woo iS, et al. Rosuvastatin does not affect fasting glucose, insulin resistance, or adiponectin in patients with mild to moderate hypertension [Jl. Chonam Med J, 2013, 49 (1): 31-37.
  • 10Skoumas J, Liontou C, Chrysohoou C, et al. Statin therapy and risk of diabetes in patients with heterozygous familial hypercholesterolemia or familial combined hyperlipidemia [ J ]. Atheroselerosis, 2014, 237 (1): 140-145.

同被引文献101

引证文献10

二级引证文献61

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部